The authors have developed the Accelera TED platform to repurpose drugs for HNSCC treatment; using in vitro assays and in vivo models. Screening a library of clinically-approved drugs identified the ...

Although several drugs in wide use at the present time benefit the majority of patients with petit-mal seizures the seizures of some patients are not controlled by commonly used medications; thus, in ...

March 12, 2009 — Results are in for the first prospective clinical trial of quinacrine for prion diseases, and they are disappointing. Investigators found the antiprotozoal did not significantly ...

During the past decades, the traditional drug discovery process has been increasingly lengthy, expensive and the rate of new drug approvals has been slow. Thus, new strategies for drug discovery and ...

The drug quinacrine does not increase survival in patients with prion disease. The results of the first major prospective study of a treatment for human prion disease in the UK are published in an ...

An obscure drug once widely used against malaria is showing such early promise against the brain-killing particles that cause mad cow disease that San Francisco doctors are already trying the drug on ...

The authors have developed the Accelera TED platform to repurpose drugs for HNSCC treatment; using in vitro assays and in vivo models The authors have developed the Accelera TED platform to repurpose ...

THIS study was undertaken as a clinical evaluation of the treatment of lupus erythematosus with a tablet composed of quinacrine, 25 mg., hydroxychloroquine, 50 mg., and chloroquine, 65 mg. ¶ Certain ...

WHAT IT MEANS: Quinacrine’s advocates praise it as accessible to even the poorest of women in rural India. Opponents criticize it for just that reason and say it is a method that the World Health ...

One of the key goals of the Lupus Foundation of America (Foundation) is to ensure people with lupus have access to the care and treatments they need. Recently, access to a few vital treatments has ...